Evaluation for NCI Surgery Branch Clinical Research Protocols
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorNational Cancer Institute (NCI)
About this trial
Background:
The National Cancer Institute Surgery Branch (NCI-SB) has developed experimental therapies that involve taking white blood cells from patients' tumor or from their blood, growing them in the laboratory in large numbers, and then giving the cells back to the patient.
Objective:
This study will allow patients to under screening and evaluation for participation in NC-SB Protocols.
Eligibility:
Patients 18 years or older must meet the minimum eligibility criteria for an NCI-SB treatment protocol.
Design
Patients will undergo testing and evaluations as required by the appropriate NCI-SB treatment protocol.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
None
Disqualifiers
None
Trial population
Patients suspected of having, or with biopsy proven, malignant disease.
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
7,000 Participants
are grouped into 1 trial groupGroup A: A/Surgery Branch Protocol Candidates
Trial outcomes
Primary outcomes
1
Number of individuals suitable for NCI Surgery Branch clinical research protocols
Total number of patients who enroll on NCI Surgery Branch clinical research protocols
Time frame
25 Years2
Frequency of HLA type, gene specific mutations, or expression of neoantigens in malignant tumors
Frequency of HLA type, gene specific mutations, or expression of neoantigens in tissue and blood samples
Time frame
25 years3
Results of screening tests
Results of screening tests for use on subsequent research protocol as baseline (e.g., pretreatment) values
Time frame
25 yearsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov